top of page

The association of circulating kynurenine, a tryptophan metabolite, with frailty in older adults. Aging (Albany NY). 2020 [참여저자]


Abstract

Despite the accumulating evidence from in vitro and animal experiments supporting the role of kynurenine (a tryptophan metabolite) in a number of degenerative age-related changes, the relationship between kynurenine and frailty in older adults is not well understood. We collected blood samples from 73 participants who underwent a comprehensive geriatric assessment, measuring kynurenine levels using liquid chromatography-tandem mass spectrometry. We assessed the phenotypic frailty and the deficit accumulation frailty index using widely validated approaches proposed by Fried et al. and Rockwood et al., respectively. After adjusting for sex, age, and body mass index, the frail participants presented 52.9% and 34.3% higher serum kynurenine levels than those with robustness and prefrailty, respectively (P = 0.005 and 0.014, respectively). Serum kynurenine levels were positively associated with the frailty index, time to complete 5 chair stands, and patient health questionnaire-2 score and inversely associated with grip strength and gait speed (P = 0.042 to <0.001). Furthermore, the odds ratio per increase in serum kynurenine level for phenotypic frailty was approximately 2.62 (95% confidence interval = 1.22-5.65, P = 0.014). These data provide clinical evidence that circulating kynurenine might be a potential biomarker for assessing the risk of frailty in humans.

Keywords: aging; biomarker; frailty; kynurenine; sarcopenia.

Figure 2. Differences in frailty-related factors according to serum kynurenine tertiles (A) before and (B) after adjusting for sex, age, and BMI. Frailty index is calculated based on the Rockwood’s proposal. The estimated means with 95% confidence intervals were generated and compared using analysis of covariance. Serum kynurenine tertiles: T1 = 0.78–1.52 μM, T2 = 1.53–2.01 μM, and T3 = 2.02–4.44 μM. * and † indicate statistically significant differences from T1 and T2 tertiles, respectively. Abbreviations: PHQ-2, patient health questionnaire-2; SPPB, short physical performance battery.

조회수 0회댓글 0개

Comments


AMC NS LAB
서울아산병원 신경외과 중환자실, 신경외과연구실, NSICU
© 2024 by NSLAB Hanwool Jeon, Hayeong Kang

3.JPG
화면 캡처 2024-10-14 183847.png
화면 캡처 2024-10-14 183511.png
화면 캡처 2024-10-14 183557.png

Section of Neurocritical Care

bottom of page